Merck Contact us
ZOSTAVAX Français    Decrease Text Size Increase Text Size     Print this page  Print Page     Share  Share  

Have you had your shingles vaccine yet?

In Canada, it is estimated that nearly 1 in 3 people will develop shingles in their lifetime.

ZOSTAVAX® is the first and only vaccine indicated to help prevent shingles in individuals 50 years of age or older.

Tell your family. Tell your friends. Help protect yourself and those you care about from this common condition that could result in potentially excruciating and debilitating long-term pain.

Don’t wait until it’s too late. Talk to your doctor or healthcare professional today about getting the shingles vaccine.

Home What is Shingles? What is ZOSTAVAX®? Where you can get vaccinated Related Links Photo Gallery Contact Us Site Map

ZOSTAVAX® is indicated for the prevention of herpes zoster (shingles) and for immunization of individuals 50 years of age or older. ZOSTAVAX® does not protect all individuals against the development of shingles or its consequences. ZOSTAVAX® cannot be used to treat existing shingles or the pain associated with existing shingles. If you get shingles even though you have been vaccinated, see your healthcare provider promptly.

ZOSTAVAX® should not be used if you: are allergic to any of the components of the vaccine, including gelatin or neomycin; have a blood disorder or any type of cancer that weakens your immune system; have been told by your doctor that you have a weakened immune system as a result of a disease, medications, or other treatment; have active untreated tuberculosis; are pregnant.

Women of childbearing age should take the necessary precautions to avoid pregnancy for 3 months following vaccination. Like all vaccines, ZOSTAVAX® can have side effects. In studies, the most common side effects were at the injection site and included redness, pain, swelling, hard lump, itching, warmth, and bruising. Headache and pain in the arm or leg were also reported. Additional side effects reported in general use with ZOSTAVAX® include allergic reactions, which may be serious and may include difficulty in breathing or swallowing, and fever. If you have an allergic reaction, call your doctor right away. Talk to your doctor or pharmacist for a more complete list of side effects for ZOSTAVAX®.

Drug Identification Number (DIN): 02315939

Merck

PAAB This site is intended for Canadian residents only.
® Registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Used under licence.
© 2009, 2011 Merck Canada Inc., a subsidiary of Merck & Co., Inc. All rights reserved.